Benjamin Tanenbaum
Impact in
-
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Protein Degradation and Inhibitors 1
- Oncology 3
- CAR-T cell therapy research 2
- Co-authors
- Shyam A. Patel (2 shared papers)Steven P. Balk (1 shared paper)Huihui Ye (1 shared paper)Housheng Hansen He (1 shared paper)Hongyun Wang (1 shared paper)Sen Chen (1 shared paper)Lingfeng He (1 shared paper)Adam G. Sowalsky (1 shared paper)
- Journals
- mSphere (1 paper)Journal of Clinical Investigation (1 paper)Leukemia Research (1 paper)Annals of Hematology (1 paper)Communications Biology (1 paper)
- Partner nations
- United StatesDenmarkIndia
In The Last Decade
Benjamin Tanenbaum
6 papers receiving 202 citations
Peers
Comparison fields: 5 of 43
- Hematology 38
- Cancer Research 41
- Oncology 45
- Molecular Biology 111
- Genetics 14
Countries citing papers authored by Benjamin Tanenbaum
This map shows the geographic impact of Benjamin Tanenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Tanenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Tanenbaum more than expected).
Fields of papers citing papers by Benjamin Tanenbaum
This network shows the impact of papers produced by Benjamin Tanenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Tanenbaum. The network helps show where Benjamin Tanenbaum may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Tanenbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 137 | |
| 2 | 2022 | 33 | |
| 3 | 2023 | 20 | |
| 4 | 2021 | 6 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 2 |
About Benjamin Tanenbaum
Benjamin Tanenbaum is a scholar working on Molecular Biology, Oncology, Immunology, Hematology and Genetics, having authored 6 papers that have together received 202 indexed citations. Recurring topics across this work include CAR-T cell therapy research (2 papers), Acute Myeloid Leukemia Research (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (1 paper), Prostate Cancer Treatment and Research (1 paper), Protein Degradation and Inhibitors (1 paper), Toxin Mechanisms and Immunotoxins (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (38 citations), Cancer Research (41 citations), Oncology (45 citations), Molecular Biology (111 citations) and Genetics (14 citations). Benjamin Tanenbaum has collaborated with scholars based in United States, Denmark and India. Frequent co-authors include Shyam A. Patel, Steven P. Balk, Huihui Ye, Housheng Hansen He, Hongyun Wang, Sen Chen, Lingfeng He, Adam G. Sowalsky, Fen Ma and Changmeng Cai. Their work appears in journals such as mSphere, Journal of Clinical Investigation, Leukemia Research, Annals of Hematology and Communications Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.